A pharmaceutical composition containing salt of strontium, vitamin D, cyclodextrin and one or more nontoxic pharmaceutically acceptable excipient or carrier, wherein mass ratio of vitamin D and cyclodextrin is 1/40-1/80; and application thereof for bone diseases or arthrosis treatment.